Pilot Study of efficacy and safety of nalfurafine hydrochloride for jaundice associated pruritus
Not Applicable
- Conditions
- Pruritus
- Registration Number
- JPRN-UMIN000033255
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Patient's consciousness are not alert. Presence of hypersensitivity to nalfurafine hydrochloride and/or fexofenadine hydrochloride. Presence of other dermatosis except for jaundice associated pruritis. Presence of sever organopathy and/or drug allergy. Patients who pregnant or possibility of pregnant, lactating and desire for childbearing. Difficult to ingestion. Ineligible cases are judged by researchers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compare with curative effect for pruritus in 2 weeks later medicating between "nalfurafine hydrochloride group" and "fexofenadine hydrochloride group".
- Secondary Outcome Measures
Name Time Method